2011 Program Co-Chairs

Christopher Kemp, PhD
President
Kempbio, Inc.
Thomas A. Kost, PhD
Director, Research Investigator
GlaxoSmithKline R & D
TOPICS:
» Plasmid and Virus Development » Feed and Harvest Strategies
» Scale-Up and Purification » Media Development
» Cell Line Development and Characterization » AAV/VLP Production and Characterization
» Protein Expression and Optimization » High-Throughput Screening Applications
» Comparison to Other Expression Technologies  

2011 Program Schedule

  Sunday, April 3, 2011

4:00 pm–7:00 pm Welcome Reception (Half Moone)

  Monday, April 4, 2011

7:00 am–8:00 am Registration and Continental Breakfast (Nauticus, 3rd Floor)

8:00 am–8:30 am Meeting Overview (Nauticus, 3rd Floor) & Exhibit Setup (Half Moone)

8:30 am–10:00 am Plenary – Contaminant Detection and Prevention (Nauticus, 3rd Floor)
& Exhibit Setup (Half Moone)

10:00 am–10:30 am Morning Break (Half Moone)

10:30 am–11:15 am Gary W. Blissard, PhD Recent Insights Into Baculovirus Entry
Mediated by Envelope Protein GP64
Scientist
Boyce Thompson Institute at Cornell University

11:15 am–12:00 pm Loy E. Volkman, PhD Baculovirus Nucleocapsid Transport to the Nucleus and Beyond!
Professor
University of California, Berkeley

12:00 pm–1:30 pm Lunch (Half Moone) and Poster Presentations from 1:00 pm-1:30 pm (Half Moone)

1:30 pm–2:15 pm Peter Pushko, PhD Expression of Influenza Virus-Like Particles (VLPs) in
Sf9 Cells Using Recombinant Baculovirus
President/CSO
Medigen, Inc.

2:15 pm–3:00 pm Kari Airenne, PhD Baculovirus-Based Lentivirus Production
in Suspension Cell Culture
Professor of Molecular Medicine
University of Eastern Finland,
A.I. Virtanen Institute

3:00 pm–3:30 pm Afternoon Break (Half Moone)

3:30 pm–4:15 pm Krista Bowman, PhD Optimizing Efficiency and Effectiveness When Producing
Proteins With the Baculovirus Expression Vector System
Senior Scientific Manager
Genentech, Inc.

4:15 pm–5:00 pm Kenneth H. Warrington, Jr., PhD Lessons in Tech Transfer from the Contract
Manufacture of VLP Vaccines in Insect Cells:
Human B19 Parvovirus and Norovirus VLP Vaccines
Principal Virologist-Group Leader
Meridian Life Science, Inc.

5:00 pm–5:45 pm Keynote Address – US Government Strategies for Medical Countermeasures
and Pandemic Influenza Vaccines
(Half Moone)
Robin A. Robinson, PhD
Director & Deputy Assistant Secretary
BARDA/ASPR/HHS

5:45 pm–8:00 pm Pirates of Hampton Roads Reception (Half Moone)

  Tuesday, April 5, 2011

7:30 am–8:30 am Continental Breakfast (Half Moone)

8:30 am–9:15 am Donald L. Jarvis, PhD Insect Protein Glycosylation Pathways
Professor
University of Wyoming

9:15 am–10:00 am Gale E. Smith, PhD Influenza Pre-Pandemic H5N1 VLPs Made Using Sf9
Insect Cells in 1,000 L Single-Use Stirred Tank Bioreactors
Vice President of Vaccine Development
Novavax, Inc.

10:00 am–10:30 am Morning Break (Half Moone)

10:30 am–12:00 pm Technology Workshops (Half Moone)

12:00 pm–1:30 pm Lunch (Half Moone) and Poster Presentations from 1:00 pm-1:30 pm (Half Moone)
plus Baculovirus Reference Material Meeting (By Invitation)

1:30 pm–2:15 pm Thera Mulvania, PhD Practical Science: Baculo Tales from the Bench
Senior Scientist/Operations
Expression Systems, LLC

2:15 pm–3:00 pm Clifton E. McPherson, PhD Development of a Novel Recombinant
Influenza Vaccine in Insect Cells
Senior Director, Quality Control
Protein Sciences Corporation

6:00 pm–9:00 pm Jazz Banquet at Scotty Quixx

  Wednesday, April 6, 2011

7:30 am–8:30 am Continental Breakfast (Half Moone)

8:30 am–9:15 am Thomas A. Kost, PhD BacMam Viruses: Versatile Biological Tools
Director, Research Investigator
GlaxoSmithKline R & D

9:15 am–10:00 am Christopher W. Kemp, PhD A Comparison of Methods for the Concentration and
Diafiltration of Baculovirus and BacMam Particles
President
Kempbio, Inc.

10:00 am–10:30 am Morning Break (Half Moone)

10:30 am–11:15 am Kevin S. Richards, PhD A Strategy for Developing Differential Immuno-Assays for
Identification and Characterization of Filovirus Sub Types
Senior Molecular Virologist
Health Protection Agency

11:15 am–12:00 pm Amine A. Kamen, PhD Efficient Manufacturing of Recombinant
AAV Serotypes Using a Baculovirus Expression System
Head Animal Cell Technology
National Research Council Canada

12:00 pm–1:30 pm Lunch (Half Moone) and Poster Presentations from 1:00 pm-1:30 pm (Half Moone)

1:30 pm–2:15 pm Kelly Warfield, PhD Ebola and Marburg Virus Vaccines
Produced Using Baculovirus Technologies
Vice President of Vaccine Development
Integrated BioTherapeutics, Inc.

2:15 pm–3:00 pm Otto-Wilhelm Merten, PhD Large-Scale Production of AAV Vectors
Using the Baculovirus Expression System
Head of Applied Vectorology and Innovation
Genethon

3:00 pm–3:30 pm Afternoon Break (Half Moone)

3:30 pm–5:00 pm Plenary – Contamination Detection and Prevention – Discussion and Wrap-Up (Nauticus, 3rd Floor) & Exhibit Teardown (Half Moone)